Australia Stock Exchange release from IMAGION BIOSYSTE : First-in-human Study Progress Update
16/03/2022 23:24
Australia Stock Exchange release from IMAGION BIOSYSTE IBX.AX : First-in-human Study Progress Update
Recent news on Imagion Biosystems
See all newsBrief: Imagion Biosystems Resumes Magsense Nanoparticle Manufacturing Capabilities
Brief: Imagion Biosystems Secures AU$3.75M In Capital Raise Following FDA Clearance Of Phase 2 Clinical Trial
Brief: Imagion Biosystems Secures A$3.75 Million In Firm Commitments Under Capital Raising
Australia's Imagion Biosystems falls on discounted placement
Brief: Imagion Biosystems Seeks Trading Halt